Publication: Mode of action and features of antimalarial drugs
Issued Date
1999-12-01
Resource Type
ISSN
0399077X
Other identifier(s)
2-s2.0-0033378543
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Medecine et Maladies Infectieuses. Vol.29, No.SUPPL. 3 (1999), 307-315
Suggested Citation
F. Nosten, N. J. White Mode of action and features of antimalarial drugs. Medecine et Maladies Infectieuses. Vol.29, No.SUPPL. 3 (1999), 307-315. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/25547
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Mode of action and features of antimalarial drugs
Author(s)
Other Contributor(s)
Abstract
The treatment for Plasmodium falciparum malaria is too often based on empirical notions of the efficacy and toxicity of drugs. Understanding the pharmacokinetic-pharmacodynamic relationships and antimalarial drugs' modes of action allows one to better understand the therapeutic responses observed in the treatment of severe or uncomplicated P. falciparum infections. The authors discuss the variations of parasitemia and their influencing factors (prevention, synchronism, virulence, and pretreatment). These factors are to be taken into account when first considering therapy. Many variables are defined to analyze the pharmacodynamic-efficacy interactions of anti-malarial drugs: minimal parasiticidal concentration (MPC) of a drug, minimum concentration in blood which produces a maximal inhibition (or maximum efficacy [Emax]), the parasitic reduction ratio (PRR), which is the relationship between the initial parasitemia over the parasitemia 48 hours after onset of treatment. These variables are specific to each drug and are useful in selecting the therapeutic answer and to better use antimalarial drugs. The main drugs and their combinations are reviewed (quinine, chloroquine, sulfadoxine-pyrimethamine, biguanides, mefloquine, halofantrine, artemisinine-based drugs), taking into account these pharmacological concepts.